The objectives of the research proposed are to define the biochemistry, function, and physiological roles of the 17beta-hydroxysteroid dehydrogenases (17beta-HSDs), a group of isozymes crucial to the biosynthesis and activation/inactivation of sex steroid hormones. Over the last four years, we isolated and characterized cDNAs and genes that encode two distinct isozymes of 17beta-HSD, designated type 2 and type 3, the biochemical properties and tissue distributions of which are different and distinct. These findings pose a number of questions relating to the physiological roles of the two isozymes, and how their different biochemical properties influence these roles. The initial goal of the studies proposed is to conduct detailed analyses of the tissue distribution, cell type-specific expression and ontogeny of the two isozymes. These analyses will be accomplished by immunoblotting, immunohistochemistry, RNA blotting, in situ mRNA hybridization, and 17beta-HSD isozyme activity assays. The second objective is to purify the type 2 isozyme to homogeneity. The kinetic, pharmacological, and structural properties of the isozyme will be determined and related to its intracellular localization and function. The third goal is to identify and characterize key mutations in the 17beta-HSD type 3 gene among male pseudohermaphrodites caused by 17beta-HSD deficiency. some of these mutations give a gent that encodes an enzyme with modified Michaelis-Menten constants for substrate or cofactor; the study of these modifications will provide important information concerning the structural domains of the protein. The identification of mutations will be accomplished using the polymerase chain reaction followed b single strand DNA conformation polymorphism and sequence analysis of amplified DNA. The final objective of this research is to expand the structure-function information derived from naturally occurring mutations by creating, and expressing a limited number of site-directed mutations in the 17beta-HSD type 3 cDNA using the baculovirus system. These studies will be focused on identifying amino acid sequences that form the cofactor and substrate binding domains of the protein. Detailed kinetic, pharmacological and structure properties of the purified mutant enzymes will be compared with those of the normal enzyme.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK052167-01A1
Application #
2387106
Study Section
Endocrinology Study Section (END)
Program Officer
Akolkar, Beena
Project Start
1997-09-30
Project End
2001-07-31
Budget Start
1997-09-30
Budget End
1998-07-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Andersson, Stefan; Minjarez, Debra; Yost, Nicole P et al. (2008) Estrogen and progesterone metabolism in the cervix during pregnancy and parturition. J Clin Endocrinol Metab 93:2366-74
Mains, Lindsay M; Vakili, Babak; Lacassie, Yves et al. (2008) 17beta-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite. Fertil Steril 89:228.e13-7
Feldkoren, Boris I; Andersson, Stefan (2005) Anabolic-androgenic steroid interaction with rat androgen receptor in vivo and in vitro: a comparative study. J Steroid Biochem Mol Biol 94:481-7
Khan, Naveed; Sharma, Kamalesh K; Andersson, Stefan et al. (2004) Human 17beta-hydroxysteroid dehydrogenases types 1, 2, and 3 catalyze bi-directional equilibrium reactions, rather than unidirectional metabolism, in HEK-293 cells. Arch Biochem Biophys 429:50-9
Lindqvist, Annika; Andersson, Stefan (2002) Biochemical properties of purified recombinant human beta-carotene 15,15'-monooxygenase. J Biol Chem 277:23942-8
McKeever, Brian M; Hawkins, Barton K; Geissler, Wayne M et al. (2002) Amino acid substitution of arginine 80 in 17beta-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics. Biochim Biophys Acta 1601:29-37
Lindqvist, A; Hughes, I A; Andersson, S (2001) Substitution mutation C268Y causes 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 86:921-3
Suzuki, T; Sasano, H; Andersson, S et al. (2000) 3beta-hydroxysteroid dehydrogenase/delta5-->4-isomerase activity associated with the human 17beta-hydroxysteroid dehydrogenase type 2 isoform. J Clin Endocrinol Metab 85:3669-72
Mendonca, B B; Inacio, M; Arnhold, I J et al. (2000) Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 79:299-309
Takeyama, J; Suzuki, T; Hirasawa, G et al. (2000) 17beta-hydroxysteroid dehydrogenase type 1 and 2 expression in the human fetus. J Clin Endocrinol Metab 85:410-6

Showing the most recent 10 out of 15 publications